Growth Metrics

Organon (OGN) Change in Accured Expenses (2020 - 2026)

Organon has reported Change in Accured Expenses over the past 7 years, most recently at $95.0 million for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 143.59% year-over-year to $95.0 million; the TTM value through Mar 2026 reached -$86.0 million, down 82.98%, while the annual FY2025 figure was -$142.0 million, 40.59% down from the prior year.
  • Change in Accured Expenses for Q1 2026 was $95.0 million at Organon, up from -$156.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $165.0 million in Q3 2023 and troughed at -$156.0 million in Q4 2025.
  • A 5-year average of $7.4 million and a median of -$8.0 million in 2022 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 950.0% in 2023 and later surged 360.0% in 2025.
  • Year by year, Change in Accured Expenses stood at $64.0 million in 2022, then increased by 6.25% to $68.0 million in 2023, then plummeted by 207.35% to -$73.0 million in 2024, then tumbled by 113.7% to -$156.0 million in 2025, then surged by 160.9% to $95.0 million in 2026.
  • Business Quant data shows Change in Accured Expenses for OGN at $95.0 million in Q1 2026, -$156.0 million in Q4 2025, and $73.0 million in Q3 2025.